Authors

Lourdes MenendezAlvarado, Baptist Health South FloridaFollow
Alice Landayan, Baptist Health South FloridaFollow
Kelsey Williams, Baptist Health South FloridaFollow
Corey Frederick, Miami Cancer InstituteFollow
Zhenwei Zhang, Baptist Health South FloridaFollow
Timothy Gauthier, Baptist Health South FloridaFollow

Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections

Publication Date

7-1-2024

Content Type

Article

PubMed ID:

38717472

Citation

Menendez Alvarado, L. R., Margulis Landayan, A., Williams, K. N., Frederick, C. M., Zhang, Z., & Gauthier, T. P. (2024). Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections. The Journal of antimicrobial chemotherapy, 79(7), 1564–1568. https://doi.org/10.1093/jac/dkae135